These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1285134)
1. The epidemiology of pertussis in England and Wales. Miller E; Vurdien JE; White JM Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R152-4. PubMed ID: 1285134 [TBL] [Abstract][Full Text] [Related]
2. The effect of an accelerated immunisation schedule on pertussis in England and Wales. White JM; Fairley CK; Owen D; Matthews RC; Miller E Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929 [TBL] [Abstract][Full Text] [Related]
3. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950 [TBL] [Abstract][Full Text] [Related]
4. Control of pertussis in the world. Galazka A World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658 [TBL] [Abstract][Full Text] [Related]
5. Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Elomaa A; He Q; Minh NN; Mertsola J Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060 [TBL] [Abstract][Full Text] [Related]
6. The 1996 pertussis epidemic in New Zealand: descriptive epidemiology. Blakely T; Mansoor O; Baker M N Z Med J; 1999 Feb; 112(1081):30-3. PubMed ID: 10078212 [TBL] [Abstract][Full Text] [Related]
7. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage. Girard DZ Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048 [TBL] [Abstract][Full Text] [Related]
8. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada. Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Gustafsson L; Hessel L; Storsaeter J; Olin P Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988 [TBL] [Abstract][Full Text] [Related]
10. [Pertussis: a reemerging infection?]. Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802 [TBL] [Abstract][Full Text] [Related]
11. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry]. Matter HC; Schmidt-Schläpfer G; Zimmermann H Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704 [TBL] [Abstract][Full Text] [Related]
13. Increase in deaths from pertussis among young infants in the United States in the 1990s. Vitek CR; Pascual FB; Baughman AL; Murphy TV Pediatr Infect Dis J; 2003 Jul; 22(7):628-34. PubMed ID: 12867839 [TBL] [Abstract][Full Text] [Related]
14. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
15. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis. Kimura M; Kuno-Sakai H Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651 [TBL] [Abstract][Full Text] [Related]
16. [The epidemiology of whooping cough]. Finger H; Wirsing von König CH Gesundheitswesen; 1992 Oct; 54(10):541-5. PubMed ID: 1450537 [TBL] [Abstract][Full Text] [Related]